Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Depreciation and Depletion (2023 - 2025)

Historic Depreciation and Depletion for Artiva Biotherapeutics (ARTV) over the last 3 years, with Q3 2025 value amounting to $600000.0.

  • Artiva Biotherapeutics' Depreciation and Depletion changed 0.0% to $600000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $2.4 million for FY2024, which is 434.78% up from last year.
  • Per Artiva Biotherapeutics' latest filing, its Depreciation and Depletion stood at $600000.0 for Q3 2025, which was down 0.0% from $600000.0 recorded in Q2 2025.
  • Over the past 5 years, Artiva Biotherapeutics' Depreciation and Depletion peaked at $600000.0 during Q3 2023, and registered a low of $500000.0 during Q2 2023.
  • Over the past 3 years, Artiva Biotherapeutics' median Depreciation and Depletion value was $600000.0 (recorded in 2023), while the average stood at $590000.0.
  • Over the last 5 years, Artiva Biotherapeutics' Depreciation and Depletion had its largest YoY gain of 2000.0% in 2024, and its largest YoY loss of 0.0% in 2024.
  • Over the past 3 years, Artiva Biotherapeutics' Depreciation and Depletion (Quarter) stood at $600000.0 in 2023, then changed by 0.0% to $600000.0 in 2024, then changed by 0.0% to $600000.0 in 2025.
  • Its Depreciation and Depletion was $600000.0 in Q3 2025, compared to $600000.0 in Q2 2025 and $600000.0 in Q1 2025.